Cardiac arrest & resuscitation
A retrospective comparison of the King Laryngeal Tube and iGel supraglottic airway devices: A study for the Cardiac Arrest Registry to Enhance Survival (CARES) surveillance group
Main finding · Neurologically favorable survivalResult — go to the resultAdjusted odds ratio 1.45 CI 1.33–1.58Authors' conclusion
This study adds to the body of literature suggesting that use of the iGel during OHCA resuscitation is associated with better outcomes than use of the King LT.
Study context
- Population
- Non-traumatic out-of-hospital cardiac arrest (OHCA) with attempted EMS resuscitation, CARES registry, 2013–2021
- Exposure
- iGel vs King LT
- Outcome
- Survival with Cerebral Performance Category (CPC) score 1 or 2
- Follow-up
- At discharge
Methodological detailsregistry-based, two-level mixed effects multivariable logistic regression
- Registry-based
- Two-level mixed effects multivariable logistic regression
Main finding
Neurologically favorable survival
Adjusted odds ratio
1.45
CI 1.33–1.58
iGel vs King LT
aOR 1.45 (CI 1.33–1.58)
As reported in the abstract
Observational data: associations, not effects.
Secondary outcomes
| Outcome | Estimate |
|---|---|
| Survival to hospital admission | 1.07 (CI 1.02–1.12) |
| Survival to hospital discharge | 1.35 (CI 1.26–1.46) |
Original publication
A retrospective comparison of the King Laryngeal Tube and iGel supraglottic airway devices: A study for the CARES surveillance group. Resuscitation. Published 28 April 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →